A Phase 1/2, Open-Label, Basket Study of Afamitresgene Autoleucel in Pediatric Subjects with MAGE-A4 Positive Tumors
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Adaptimmune LLC
Start Date
March 8, 2024
End Date
June 30, 2038
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Adaptimmune LLC
Start Date
March 8, 2024
End Date
June 30, 2038